Skip to main content

Table 2 Factors associated with a delay in symptomatic presentation of more than 3 months (among 141 patients reporting any symptoms and with data on time to presentation available)

From: Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study

  

N (%) delaying presentation

Odds ratio for delay

95% CI

p

Age (years)

<40

6/12 (50.0)

1.00

  

40–64

19/57 (33.3)

0.50

0.14–1.76

0.28

≥65

13/60 (21.7)

0.28

0.08–1.00

0.05

Sex

Male

16/66 (24.2)

1.00

  

Female

24/75 (32.0)

1.32

0.77–2.26

0.32

Site of primary melanoma

Head and neck

8/22 (36.4)

1.00

  

Trunk

9/43 (20.9)

0.46

0.15–1.45

0.19

Limbs

21/71 (29.6)

0.74

0.27–2.01

0.55

Unspecified

2/5 (40.0)

1.17

0.16–8.53

0.88

New lump on skin or new mole

No

31/119 (26.1)

1.00

  

Yes

9/22 (40.9)

1.97

0.77–5.05

0.16

Mole changing shape or colour or growing bigger

No

11/57 (19.3)

1.00

  

Yes

29/84 (34.5)

2.20

0.99–4.89

0.05

Mole growing bigger

No

18/85 (21.2)

1.00

  

Yes

22/56 (39.3)

2.04

1.14–5.08

0.02

Mole changing colour

No

22/94 (23.4)

1.00

  

Yes

18/47 (38.3)

2.03

0.95–4.33

0.07

Mole changing shape

No

24/99 (24.2)

1.00

  

Yes

16/42 (38.1)

1.92

0.89–4.17

0.10

Mole itchy

No

29/112 (25.9)

1.00

  

Yes

11/29 (37.9)

1.75

0.74–4.14

0.20

Mole bleeding or crusting

No

33/103 (32.0)

1.00

  

Yes

7/38 (18.4)

0.47

0.19–1.20

0.12

  1. The odds ratio for delay was not calculated for a lump in the neck, groin or armpit as no patients reporting this symptom had a delayed presentation. For the odds ratios by symptom, the reference group is the group of patients who did not report that particular symptom. Age at diagnosis was available for 129 of the 141 patients reported in this table